Impact of concomitant methotrexate on JAK inhibitors in rheumatoid arthritis-associated interstitial lung disease: a retrospective single-centre study from the KEIO-RA cohort
In RA-ILD, our study found no significant differences in the effectiveness of JAK inhibitors for both ILD and arthritis, retention, and safety, with or without MTX.
Authors
- Kanako Shimanuki (ORCID: https://orcid.org/0009-0006-0001-1078)
- K. Suzuki
- Mitsuhiro Akiyama (ORCID: https://orcid.org/0000-0001-5075-8977)
- Yuko Kaneko
Institutions
- Keio University (JP)
Publication Details
- Journal
- Clinical and Experimental Rheumatology
- Published
- 2025-09-21
- DOI
- https://doi.org/10.55563/clinexprheumatol/tiu2h4
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eisai